Ophthalmology · Boca Raton, FL
NPI
1174545545
Since 2006
Specialty
Ophthalmology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
950 NW 13th St
Boca Raton, FL, 33486
Phone (561) 391-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
36,863 services
Medicare patients, 2024
1,266
Average age 81
Drug cost, 2024
$771K
672 prescriptions
Company payments, 2025
$543
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ernesto I Segal was code J2777 (injection, faricimab-svoa, 0.1 mg), 25,860 times for 66 patients. In total Ernesto I Segal billed 36,863 services in 30 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 25,860 | 66 | $27.42 | $709K |
| 92134 Computerized Ophthalmic Imaging | Office | 2,281 | 1,087 | $31.68 | $72K |
| 92014 Ophthalmological E&M | Office | 2,051 | 1,171 | $98.80 | $203K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,780 | 191 | $659.14 | $1.2M |
| 67028 Intravitreal Injection | Office | 1,337 | 266 | $97.87 | $131K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 824 | 19 | $264.39 | $218K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 720 | 12 | $117.24 | $84K |
| 92012 Ophthalmological E&M | Office | 703 | 236 | $73.27 | $52K |
| 92250 Angiography | Office | 332 | 303 | $28.65 | $9,513 |
| 92201 Ophthalmological E&M | Office | 321 | 271 | $19.73 | $6,334 |
| 76512 Ultrasound - Nonspecific | Office | 132 | 108 | $38.98 | $5,145 |
| 92235 Angiography | Office | 78 | 75 | $125.31 | $9,775 |
| 92004 Ophthalmological E&M | Office | 78 | 78 | $106.71 | $8,323 |
| 92083 Vision, Hearing, and Speech Services | Office | 42 | 41 | $52.93 | $2,223 |
| 92133 Computerized Ophthalmic Imaging | Office | 22 | 22 | $25.32 | $557 |
By year: 2022 $2.6M for 11,679 services; 2023 $2.7M for 23,437 services; 2024 $2.7M for 36,863 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ernesto I Segal prescribed most often to Medicare patients was Eylea (Aflibercept), with 143 prescriptions and refills. In total Ernesto I Segal wrote 672 Medicare prescriptions that cost $771K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 143 | 159 | 36 | $299K |
| Prednisolone Acetate Generic | 85 | 112 | 59 | $3,287 |
| Ketorolac Tromethamine Generic | 83 | 105 | 31 | $1,564 |
| Eylea Hd Aflibercept | 74 | 86 | 16 | $247K |
| Latanoprost Generic | 50 | 119 | 15 | $373 |
| Vabysmo Faricimab-Svoa | 46 | 46 | Under 11 | $150K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 30 | 31 | 24 | $762 |
| Timolol Maleate Generic | 24 | 65 | Under 11 | $343 |
| Restasis Cyclosporine | 22 | 47 | Under 11 | $27K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 12 | 12 | 12 | $126 |
Brand drugs: 452 claims; generic drugs: 220 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ernesto I Segal $543 ($543 in general payments such as food, travel and fees) from 10 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $188.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $188 |
| Astellas Pharma US Inc 4503.T | 3 | $172 |
| Abbvie Inc. ABBV | 2 | $42.95 |
| Harrow Eye, LLC | 1 | $26.9 |
| Alcon Vision LLC ALC | 1 | $23.07 |
| Genentech USA, Inc. ROG.SW | 1 | $21.78 |
| Bausch & Lomb Americas Inc. BLCO | 1 | $19.49 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $18.26 |
| Amgen Inc. AMGN | 1 | $15.18 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $14.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.